Impact of digoxin versus beta-blocker in patients with coexistent atrial fibrillation and heart failure: a target trial emulation — Lin Liu (2025) | RDL Network
Impact of digoxin versus beta-blocker in patients with coexistent atrial fibrillation and heart failure: a target trial emulation
Article 2025 en
Authors
LL
Lin Liu
AC
Anping Cai
JH
Jiayi Huang
Abstract
1 min read
In patients with coexisting AF and HF, digoxin was associated with significantly higher risks of all-cause mortality, cardiovascular mortality, and heart failure hospitalization compared to beta-blocker.
Krzysztof Ozierański, Agnieszka Kapłon‐Cieślicka, Paweł Balsam, Agata Tymińska, Anna Wancerz, Michał Peller, Michał Marchel, María G. Crespo‐Leiro, Aldo Maggioni, Jarosław Dróżdż, Krzysztof J. Filipiak, Grzegorz Opolski
Inder S. Anand, Changhong Yu, Marc A. Pfeffer, John J.V. McMurray, Akshay S. Desai, Scott D. Solomon, Dirk J. ban Veldhuisen, Sunfa Cheng, Kurt Olson, Aldo Maggioni, Karl Swedberg, James B. Young
Discussion(0)
No comments yet. Be the first to comment.